Target Binding Site Detail
Target General Information | Top | ||||
---|---|---|---|---|---|
Target ID | T70518 | Target Info | |||
Target Name | S-nitrosoglutathione reductase (CBR1) | ||||
Synonyms | ProstaglandinE(2) 9reductase; Prostaglandin 9ketoreductase; NADPHdependent carbonyl reductase 1; Carbonyl reductase [NADPH] 1; CBR1; 15hydroxyprostaglandin dehydrogenase [NADP(+)] | ||||
Target Type | Clinical trial Target | ||||
Gene Name | CBR1 | ||||
Biochemical Class | Short-chain dehydrogenases reductase | ||||
UniProt ID |
Ligand General Information | Top | ||||
---|---|---|---|---|---|
Ligand Name | NADPH | Ligand Info | |||
Canonical SMILES | C1C=CN(C=C1C(=O)N)C2C(C(C(O2)COP(=O)(O)OP(=O)(O)OCC3C(C(C(O3)N4C=NC5=C(N=CN=C54)N)OP(=O)(O)O)O)O)O | ||||
InChI | 1S/C21H30N7O17P3/c22-17-12-19(25-7-24-17)28(8-26-12)21-16(44-46(33,34)35)14(30)11(43-21)6-41-48(38,39)45-47(36,37)40-5-10-13(29)15(31)20(42-10)27-3-1-2-9(4-27)18(23)32/h1,3-4,7-8,10-11,13-16,20-21,29-31H,2,5-6H2,(H2,23,32)(H,36,37)(H,38,39)(H2,22,24,25)(H2,33,34,35)/t10-,11-,13-,14-,15-,16-,20-,21-/m1/s1 | ||||
InChIKey | ACFIXJIJDZMPPO-NNYOXOHSSA-N | ||||
PubChem Compound ID | 5884 |
Drug Binding Sites of Target | Top | |||||
---|---|---|---|---|---|---|
PDB ID: 1WMA Crystal structure of human CBR1 in complex with Hydroxy-PP | ||||||
Method | X-ray diffraction | Resolution | 1.24 Å | Mutation | No | [1] |
PDB Sequence |
SGIHVALVTG
11 GNKGIGLAIV21 RDLCRLFSGD31 VVLTARDVTR41 GQAAVQQLQA51 EGLSPRFHQL 61 DIDDLQSIRA71 LRDFLRKEYG81 GLDVLVNNAG91 IAFKVADPTP101 FHIQAEVTMK 111 TNFFGTRDVC121 TELLPLIKPQ131 GRVVNVSSIM141 SVRALKSCSP151 ELQQKFRSET 161 ITEEELVGLM171 NKFVEDTKKG181 VHQKEGWPSS191 AYGVTKIGVT201 VLSRIHARKL 211 SEQRKGDKIL221 LNACCPGWVR231 TDMAGPKATK241 SPEEGAETPV251 YLALLPPDAE 261 GPHGQFVSEK271 RVEQW
|
|||||
|
GLY11
3.263
GLY12
3.964
ASN13
2.793
LYS14
3.435
GLY15
3.481
ILE16
2.853
GLY17
4.365
ARG37
2.800
ASP38
4.575
ARG41
4.128
LEU61
3.528
ASP62
2.968
ILE63
3.031
ASP64
3.400
ASN89
2.790
ALA90
3.539
GLY91
3.565
|
|||||
PDB ID: 4Z3D Human carbonyl reductase 1 with glutathione in a protective configuration | ||||||
Method | X-ray diffraction | Resolution | 1.80 Å | Mutation | No | [2] |
PDB Sequence |
SSGIHVALVT
10 GGNKGIGLAI20 VRDLCRLFSG30 DVVLTARDVT40 RGQAAVQQLQ50 AEGLSPRFHQ 60 LDIDDLQSIR70 ALRDFLRKEY80 GGLDVLVNNA90 GIAFKVADPT100 PFHIQAEVTM 110 KTNFFGTRDV120 CTELLPLIKP130 QGRVVNVSSI140 MSVRALKSCS150 PELQQKFRSE 160 TITEEELVGL170 MNKFVEDTKK180 GVHQKEGWPS190 SAYGVTKIGV200 TVLSRIHARK 210 LSEQRKGDKI220 LLNACCPGWV230 RTDMAGPKAT240 KSPEEGAETP250 VYLALLPPDA 260 EGPHGQFVSE270 KRVEQW
|
|||||
|
GLY11
3.299
GLY12
4.135
ASN13
2.790
LYS14
3.579
GLY15
3.490
ILE16
2.824
GLY17
4.312
ARG37
2.897
ASP38
4.699
ARG41
2.720
LEU61
3.411
ASP62
3.008
ILE63
3.015
ASP64
3.020
ASN89
2.734
ALA90
3.579
GLY91
3.529
|
References | Top | ||||
---|---|---|---|---|---|
REF 1 | An unbiased cell morphology-based screen for new, biologically active small molecules. PLoS Biol. 2005 May;3(5):e128. | ||||
REF 2 | Structural insights on the catalytic site protection of human carbonyl reductase 1 by glutathione. J Struct Biol. 2015 Oct;192(1):138-44. |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.